As the expression level of CCT/TRiC does not correlate with its activity and to better understand how the latter is modulated in cancer cells, we quantified CCT/TRiC activity modulators, prefoldin, Hop/p60 and PhLP3, in the cell lysates. The gene discussed is TXNDC9; the disease is cancer.